—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
Clinica Chimica Acta《临床化学学报》
月刊 - 荷兰
  • Clinica Chimica Acta《临床化学学报》
  • SCIE外文期刊
  • 期发文量40
  • 国人占比37.82%
  • 知网外文库
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:3区
    OA期刊:混合
  • 综述期刊:
    TOP期刊:
  • 期均国文:15
    环比增速:-68.97%
  • 期刊信息

  • 研究方向:医学-MEDICAL LABORATORY TECHNOLOGY医学实验技术
  • 国际刊号:ISSN 0009-8981;EISSN 1873-3492
  • 期刊语言:英语
    出版地区:荷兰
  • 投稿网址:https://www.editorialmanager.com/ccacta/default.aspx
  • 电子邮箱:
  • 期刊官网:https://www.journals.elsevier.com/clinica-chimica-acta
  • 作者指南:
  • 出版商网址:http://www.elsevier.com
  • 出版地址:RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX
  • 期刊简介:Clinica Chimica Acta《临床化学学报》(月刊). Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.

  • 万维提示


  • 1、投稿方式:在线投稿。

    2、期刊网址:

    https://www.journals.elsevier.com/clinica-chimica-acta

    https://www.sciencedirect.com/journal/clinica-chimica-acta

    3、投稿网址:

    https://www.editorialmanager.com/ccacta/default.aspx

    4、官网邮箱:us-cca@comcast.net

    joris.delanghe@ugent.be

    Gmakowski@clpct.com

    5、期刊刊期:月刊,一年出版12期。

    2022119日星期三

                                  

     

    投稿须知【官网信息】

     

    Guide for Authors

    INTRODUCTION

    Clinica Chimica Acta is a high quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.

    The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.

    Types of paper

    Full-length research articles, Review articles, and Case Reports.

    Reports of new or improved methods should be as brief as is consistent with clarity (up to about 1,000 words). They should unequivocally identify the element of novelty claimed and the advantages over existing technology. Performance characteristics, including effects of interfering substances, comparisons with results of accepted methods and references values based on appropriate population samples should be documented by adequate data. Citing of earlier publications is preferred to repetition of details for reagents, procedures, etc., which are always in print. Nevertheless, the information provided must suffice to allow readers to duplicate the work or to compare the technique with current practice.

    Reviews are normally invited, however the Reviews Editor welcomes suggestions of potential topics and potential authors.

    Contact details for submission

    Papers should be submitted using the Clinica Chimica Acta online submission system https://www.editorialmanager.com/ccacta/default.aspx. For questions on the submission and reviewing process, please contact the relevant Editorial Office.

    For the Americas, Japan and Asia:

    Alan H. Wu, San Francisco General Hospital us-cca@comcast.net

    For Europe, Australia and all other territories:

    Joris Delanghe, University Hospital Gent joris.delanghe@ugent.be

    Reviews from all areas:

    Greg S. Makowski Gmakowski@clpct.com

    Please note that reviews are normally invited, however the Reviews Editor welcomes suggestions of potential topics and potential authors.

    Page charges

    This journal has no page charges.

    Submission checklist

    You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

    ……

    更多详情:

    https://www.elsevier.com/journals/clinica-chimica-acta/0009-8981/guide-for-authors






欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码